Burden of disease due to dementia in the elderly population of Korea: present and future

BMC Public Health

Hae-Kwan Cheong²  Bolor Bold¹  Jin-Hee Eum¹  Jae-Hyun Park² 

[1] Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 440-746, Republic of Korea;Center for Molecular Medicine, Samsung Biomedical Research Institute, Seoul, Republic of Korea

关键词: Alzheimer's disease;    DALY;    Burden of disease;    Dementia;   

Others  :  1162387
DOI  :  10.1186/1471-2458-13-293

 received in 2012-10-09, accepted in 2013-03-27,  发布年份 2013

【 摘 要 】

Background

With the rapid aging of populations around the world, dementia has become one of the most important public health problems in Eastern Asian countries. The purpose of the present study was to provide an estimate of the burden of dementia and forecast its future burden, as generalized to the Korean population, and to provide detailed gender- and age-specific information regarding the burden of dementia in the elderly population of Korea.

Methods

‘Disability-adjusted life years’ (DALYs) were used to estimate the burden of dementia. Epidemiologic data from national statistics and nationwide epidemiologic studies in the year 2008 were used to obtain representative outcomes for the Korean population. We estimated the DALYs due to dementia from the years 2010 to 2050 by applying demographic structure projections in terms of 5-year age groups in Korea.

Results

The burden of disease due to dementia in Korea is 528 per 100,000 population (males: 435, females: 622) and 5,117 per 100,000 in those over the age of 65 years (males: 5,228; females: 5,041); this accounts for 4.5% of the total burden of disease in the year 2008. In the year 2050, DALYs due to dementia (814,629) are expected to be 3.0 times higher than those in the year 2010 (274,849).

Conclusion

Dementia has the highest burden of disease in the elderly Korean population, and this burden will increase sharply with the aging of the population. More comprehensive and multi-dimensional approaches, including clinical, psychological, social, and political means will be needed for the management of the dramatically increasing burden of dementia.

【 授权许可】

   
2013 Park et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Guehne U, Riedel-Heller S, Angermeyer MC: Mortality in dementia. Neuroepidemiology 2005, 25:153-162.
• [2]Schneider J, Murray J, Banerjee S, Mann A: EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer’s disease: I - Factors associated with carer burden. Int J Geriatr Psychiatry 1999, 14:651-661.
• [3]Prince M, 10/66 Dementia Research Group: Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry 2004, 19:170-177.
• [4]Agüero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B: Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 1998, 46:444-452.
• [5]Agüero-Torres H, Fratiglioni L, Guo Z, Viitanen M, von Strauss E, Winblad B: Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health 1998, 88:1452-1456.
• [6]World Health Organization: World Health Report 2002 – Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization; 2002.
• [7]Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM: Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007, 3:186-191.
• [8]Fratiglioni L, De Ronchi D, Agüero-Torres H: Worldwide prevalence and incidence of dementia. Drugs Aging 1999, 15:365-375.
• [9]Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M: National Burden of Disease Studies: A Practical Guide. In Global Program on Evidence for Health Policy. 20th edition. Geneva: World Health Organization; 2001.
• [10]World Health Organization: World Health Report 2003. Shaping the Future. Geneva: World Health Organization; 2003.
• [11]Prince M: The need for research on dementia in developing countries. Trop Med Health 1997, 2:993-1000.
• [12]Wimo A, Winblad B, Aguero-Torres H, von Strauss E: The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 2003, 17:63-67.
• [13]Dementia Research Group: Methodological issues in population-based research into dementia in developing countries: a position paper from the 10/66 Dementia Research Group. Int J Geriatr Psychiatry 2000, 15:21-30.
• [14]Chandra V, Ganguli M, Pandav R, Johnston J, Belle SH, Ratcliff G, Ganguli M: Prevalence of Alzheimer’s disease and other dementias in rural India: the Indo-US study. Neurology 1998, 51:1000-1008.
• [15]Hendrie HC, Osuntokun BO, Hall KS, Ogunniyi AO, Hui SL, Unverzagt FW, Gureje O, Rodenberg CA, Baiyewu O, Musick BS: Prevalence of Alzheimer’s disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 1995, 152:1485-1492.
• [16]Statistics Korea: Population of Korea 2008. http://kosis.kr/eng/database/database_001000.jsp?listid=B&subtitle=#jsClick webcite. Accessed on Feb 28 2013
• [17]Mathers C, Leonardi M: Global Burden of Dementia in the Year 2000: Summary of Methods and Data Sources. GBD 2000 Working Paper. Geneva: World Health Organization; 2000.
• [18]Alzheimer Disease International: World Alzheimer Report 2009. London: Alzheimer's Disease International; 2009:25-46.
• [19]Kim KW, Park JH, Kim MH, Kim MD, Kim BJ, Kim SK, Kim JL, Moon SW, Bae JN, Woo JI, Ryu SH, Yoon JC, Lee NJ, Lee DY, Lee DW, Lee SB, Lee JJ, Lee JY, Lee CU, Chang SM, Jhoo JH, Cho MJ: A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea. J Alzheimers Dis 2011, 23:281-291.
• [20]Cho MJ: Nationwide study on the prevalence of dementia in Korean Elders. Seoul: Seoul National University Hospital. Ministry of Health, Welfare, and Family Affairs; 2008:227.
• [21]Statistics Korea: Cause of death statistics 2008. http://kosis.kr/eng/database/database_001000.jsp?listid=Z webcite. Accessed on Feb 28 2013
• [22]World Health Organization DISMOD-IIhttp://www.who.int/healthinfo/global_burden_disease/tools_software/en/ webcite. Accessed on Feb 28 2013
• [23]Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ: A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr 2003, 1:4. BioMed Central Full Text
• [24]Lee JK, Yoon SJ, Do YK, Kwon YH, Kim CY, Park K, Kim YI, Shin YS: Disability weights for diseases in Korea. Korean J Prev Med 2003, 2:163-170.
• [25]Murray CJ, Lopez AD: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Boston, MA: Harvard University Press; 1996:1-98.
• [26]Statistics Korea: 2008 Life Tables for Korea. http://kosis.kr/eng/database/ webcite 456database_001000.jsp?listid=B&subtitle=Population,%20Household. Accessed on February 1, 2012
• [27]Statistics Korea: Population projections 2010–2050. http://kosis.kr/eng/database/database_001000.jsp?listid=B&subtitle==#jsClick webcite. Accessed on Feb 28 2013
• [28]World Health Organization: Death and DALY Estimates for 2004 by Cause for WHO Member States. http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html webcite. Accessed on February 1, 2012
• [29]Kinsella K, He W: An aging world: 2008. International Population Reports. Washington D.C: U.S. Government Printing Office; 2009. [P95/09-1. U.S. Census Bureau]
• [30]Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A: Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995, 310:970-973.
• [31]O’Connor DW, Pollitt PA, Hyde JB: The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand 1989, 79:190-198.
• [32]Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO: Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA 1989, 262:2551-2556.
• [33]Rocca WA, Bonaiuto S, Lippi A, Luciani P, Turtù F, Cavarzeran F, Amaducci L: Prevalence of clinically diagnosed Alzheimer’s disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy. Neurology 1990, 40:626-631.
• [34]Dartigues JF, Helmer C, Letenneur L, Péres K, Amieva H, Auriacombe S, Orgogozo JM, Commenges D, Jacqmin-Gadda H, Richard-Harston S, Delva F, Foubert-Samier A, Barberger-Gateau P: Paquid 2012: illustration and overview. Geriatr Psychol Neuropsychiatr Vieil 2012, 10:325-331.
• [35]Canadian Study of Health and Aging Working Group: Canadian study of health and aging: study methods and prevalence of dementia. Can Med Assoc J 1994, 150:899-913.
• [36]Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K, Ericsson K, Bäckman L, Ahlbom A, Winblad B: Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991, 41:1886-1892.
• [37]Ueda K, Kawano H, Hasuo Y, Fujishima M: Prevalence and etiology of dementia in a Japanese community. Stroke 1992, 23:798-803.
• [38]Hasegawa K: The clinical issues of age-related dementia. Tohoku J Exp Med 1990, 161:29-38.
• [39]Yamada M, Sasaki H, Mimori Y, Kasagi F, Sudoh S, Ikeda J, Hosoda Y, Nakamura S, Kodama K: Prevalence and risks of dementia in the Japanese population: RERF’s adult health study Hiroshima subjects. Radiation Effects Research Foundation. J Am Geriatr Soc 1999, 47:189-195.
• [40]Shibayama H, Kasahara Y, Kobayashi H: Prevalence of dementia in a Japanese elderly population. Acta Psychiatr Scand 1986, 74:144-151.
• [41]Jorm AF, Korten AE, Henderson AS: The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987, 76:465-479.
• [42]Hofman A, Rocca WA, Breteler MM BC, Clarke M, Cooper B, Copeland JR, Dartigues JF, da Silva Droux A, Hagnell O, Heeren TJ, Engedal K, Jonker C, Lindesay J, Lobo A, Mann AH, Moelsae PK, Morgan K, O’Connor DW, Sulkava R, Kay DW, Amaducci L, EURODEM Prevalence Research Group: The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 1991, 20:736-748.
• [43]Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S: The public health impact of Alzheimer's disease, 2000–2050: potential implication of treatment advances. Annu Rev Public Health 2002, 23:213-231.